Skip to main content
Top
Published in: Journal of Urban Health 2/2006

01-03-2006

Hospital Utilization for Injection Drug Use-Related Soft Tissue Infections in Urban versus Rural Counties in California

Authors: Keith G. Heinzerling, David A. Etzioni, Brian Hurley, BA, Paul Holtom, Ricky N. Bluthenthal, Steven M. Asch

Published in: Journal of Urban Health | Issue 2/2006

Login to get access

Abstract

Drug related-soft tissue infections (DR-STIs) are a significant source of hospital utilization in inner-city urban areas where injection drug use is common but the magnitude of hospital utilization for DR-STIs outside of inner-city urban areas is not known. We described the magnitude and characteristics of hospital utilization for DR-STIs in urban versus rural counties in California. All discharges from all nonfederal hospitals in California in 2000 with ICD-9 codes for a soft tissue infection and for drug dependence/abuse were abstracted from the California Office of Statewide Health Planning and Development discharge database. There were 4,152 DR-STI discharges in 2000 from hospitals in 49 of California's 58 counties. Residents of 12 large metropolitan counties accounted for 3,598 discharges (87% of total). The majority of DR-STI discharges were from urban safety net hospitals with county indigent programs and Medicaid as the expected payment source and opiate related discharge diagnoses. Hospital utilization for DR-STIs in California is highest in large urban metropolitan counties, although DR-STI discharges are widespread. Increased access to harm reduction services and drug treatment may reduce government health care expenditures by preventing unnecessary hospital utilization for DR-STIs.
Literature
1.
go back to reference Ochoa KC, Hair TL, Heinzerling KG, Hyde J. Abscesses and cellulitis common among injection drug users attending needle exchange, American Public Health Association Annual Meeting, San Francisco, California, November 15–19, 2003. Ochoa KC, Hair TL, Heinzerling KG, Hyde J. Abscesses and cellulitis common among injection drug users attending needle exchange, American Public Health Association Annual Meeting, San Francisco, California, November 15–19, 2003.
2.
go back to reference Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis. 2000;30:579–581.CrossRefPubMed Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis. 2000;30:579–581.CrossRefPubMed
3.
go back to reference Murphy EL, DeVita D, Liu H, et al. Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis. 2001;33:35–40.CrossRefPubMed Murphy EL, DeVita D, Liu H, et al. Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis. 2001;33:35–40.CrossRefPubMed
4.
go back to reference Vlahov D, Sullivan M, Astemborski J, Nelson KE. Bacterial infections and skin cleaning prior to injection among intravenous drug users. Public Health Rep. 1992;107:595–598.PubMed Vlahov D, Sullivan M, Astemborski J, Nelson KE. Bacterial infections and skin cleaning prior to injection among intravenous drug users. Public Health Rep. 1992;107:595–598.PubMed
5.
go back to reference Spijkerman IJ, van Ameijden EJ, Mientjes GH, Coutinho RA, van den Hoek A. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol. 1996;49:1149–1154.CrossRefPubMed Spijkerman IJ, van Ameijden EJ, Mientjes GH, Coutinho RA, van den Hoek A. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol. 1996;49:1149–1154.CrossRefPubMed
6.
go back to reference Centers for Disease Control and Prevention. Soft tissue infections among injection drug users—San Francisco, California, 1996–2000. MMWR Morb Mortal Wkly Rep. 2001;50:381–384. Centers for Disease Control and Prevention. Soft tissue infections among injection drug users—San Francisco, California, 1996–2000. MMWR Morb Mortal Wkly Rep. 2001;50:381–384.
7.
go back to reference Centers for Disease Control and Prevention. Trends in injection drug use among persons entering addiction treatment—New Jersey, 1992–1999. MMWR Morb Mortal Wkly Rep. 2001;50:378–381. Centers for Disease Control and Prevention. Trends in injection drug use among persons entering addiction treatment—New Jersey, 1992–1999. MMWR Morb Mortal Wkly Rep. 2001;50:378–381.
8.
go back to reference Falck RS, Siegal HA, Wang J, Carlson RG, Draus PJ. Nonmedical drug use among stimulant-using adults in small towns in rural Ohio. J Subst Abuse Treat. 2005;28:341–349.CrossRefPubMed Falck RS, Siegal HA, Wang J, Carlson RG, Draus PJ. Nonmedical drug use among stimulant-using adults in small towns in rural Ohio. J Subst Abuse Treat. 2005;28:341–349.CrossRefPubMed
9.
go back to reference Office of Budget and Management. Standards for defining metropolitan and micropolitan statistical areas, notice. Fed Regist. 2000;65:82228–82238. Office of Budget and Management. Standards for defining metropolitan and micropolitan statistical areas, notice. Fed Regist. 2000;65:82228–82238.
10.
go back to reference Gordis L. Epidemiology. Philadelphia: W.B. Saunders; 2000:xii, 308 p. Gordis L. Epidemiology. Philadelphia: W.B. Saunders; 2000:xii, 308 p.
11.
go back to reference United States Census Bureau. California Population Report, 2000 Census. 2000. United States Census Bureau. California Population Report, 2000 Census. 2000.
12.
go back to reference Friedman SR, Tempalski B, Cooper H, et al. Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. J Urban Health. 2004;81:377–400.PubMed Friedman SR, Tempalski B, Cooper H, et al. Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. J Urban Health. 2004;81:377–400.PubMed
13.
go back to reference Ciccarone D, Bourgois P. Explaining the geographical variation of HIV among injection drug users in the United States. Subst Use Misuse. 2003;38:2049–2063.CrossRefPubMed Ciccarone D, Bourgois P. Explaining the geographical variation of HIV among injection drug users in the United States. Subst Use Misuse. 2003;38:2049–2063.CrossRefPubMed
14.
go back to reference Lonergan S, Rodriguez RM, Schaulis M, Navaran P. A case series of patients with black tar heroin-associated necrotizing fasciitis. J Emerg Med. 2004;26:47–50.CrossRefPubMed Lonergan S, Rodriguez RM, Schaulis M, Navaran P. A case series of patients with black tar heroin-associated necrotizing fasciitis. J Emerg Med. 2004;26:47–50.CrossRefPubMed
15.
go back to reference Grau LE, Arevalo S, Catchpool C, Heimer R. Expanding harm reduction services through a wound and abscess clinic. Am J Public Health. 2002;92:1915–1917.PubMedCrossRef Grau LE, Arevalo S, Catchpool C, Heimer R. Expanding harm reduction services through a wound and abscess clinic. Am J Public Health. 2002;92:1915–1917.PubMedCrossRef
16.
go back to reference Human Rights Watch. Injecting Reason: Human Rights and HIV Prevention for Injection Drug Users. New York: Human Rights Watch, 2003. Human Rights Watch. Injecting Reason: Human Rights and HIV Prevention for Injection Drug Users. New York: Human Rights Watch, 2003.
17.
go back to reference Harris HW, Young DM. Care of injection drug users with soft tissue infections in San Francisco, California. Arch Surg. 2002;137:1217–1222.CrossRefPubMed Harris HW, Young DM. Care of injection drug users with soft tissue infections in San Francisco, California. Arch Surg. 2002;137:1217–1222.CrossRefPubMed
18.
go back to reference Dominitz JA, Boyko EJ, Koepsell TD, et al. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology. 2005;41:88–96.CrossRefPubMed Dominitz JA, Boyko EJ, Koepsell TD, et al. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology. 2005;41:88–96.CrossRefPubMed
Metadata
Title
Hospital Utilization for Injection Drug Use-Related Soft Tissue Infections in Urban versus Rural Counties in California
Authors
Keith G. Heinzerling
David A. Etzioni
Brian Hurley, BA
Paul Holtom
Ricky N. Bluthenthal
Steven M. Asch
Publication date
01-03-2006
Publisher
Springer US
Published in
Journal of Urban Health / Issue 2/2006
Print ISSN: 1099-3460
Electronic ISSN: 1468-2869
DOI
https://doi.org/10.1007/s11524-005-9021-6

Other articles of this Issue 2/2006

Journal of Urban Health 2/2006 Go to the issue